By early November 2020, the aim of the UK Government and the EU is to have an agreement in place on the future relationship between both sides.

As all industry insiders know, having the capability to cost effectively manage QC Batch release of drug product can be a costly and time-consuming process especially given such wide variations in process, service levels and price.

Having a partner to help MA Holders and manufacturers navigate this is essential especially given how long it can take to transfer methods to a lab so having the right partner is critical.

How the Tentamus Group can support you

Tentamus Group have a specialist Pharma division spanning both the UK and EU and have well established laboratories who have both the capability and capacity to help rapidly get products tested for release on both sides of the Channel.

Tentamus Pharma can provide both chemistry and microbiology and even independent contract QP services where required.

Everything is cGMP and our expert Quality Managers can help expedite audits even in these difficult times with virtual meetings and document sharing.

We aim to help you get your products to market as quickly and efficiently as possible.

If you would like more information or want to speak to someone, please use the contact form by clicking on the link below and someone will respond with a phone call or email to help.

https://www.tentamus.com/contact

Read more about our Brexit Services here: https://www.tentamus.com/brexit-pharma-no-deal/

Über die Tentamus Group GmbH

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 65 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com

Ansprechpartner:
Sharad Vora
Pharmaceutical Sales Manager
Telefon: +44 (0)7957 957 116
E-Mail: sharad.vora@tentamus.com
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel